Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX and Avastin in elderly patients with metastatic colorectal cancer
NCT01024504Phase 2Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Mar 2006
- Primary completion
- Mar 2010
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, capecitabine, oxaliplatin in colorectal cancer (metastatic) (mCRC), sponsored by Hellenic Oncology Research Group. Started Mar 2006; status: completed.
02
Drugs
bevacizumabcapecitabineoxaliplatin
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01024504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01024504.